Aberrant dimerization of von Willebrand factor as the result of mutations in the carboxy-terminal region: identification of 3 mutations in members of 3 different families with type 2A (phenotype IID) von Willebrand disease
- PMID: 11468166
- DOI: 10.1182/blood.v98.3.674
Aberrant dimerization of von Willebrand factor as the result of mutations in the carboxy-terminal region: identification of 3 mutations in members of 3 different families with type 2A (phenotype IID) von Willebrand disease
Abstract
The 3' end of the VWF gene was screened in the affected members of 3 different families with type 2A (phenotype IID) von Willebrand disease (vWD). Exons 49 to 52 of the VWF gene were amplified and screened for mutations by chemical cleavage mismatch detection. Mismatched bands were detected in exon 52 of 2 patients and in exon 51 of a third patient. Using direct DNA sequencing, a heterozygous G8562A transition leading to a Cys2008Tyr substitution was found in all the patients in family 1, and a T8561A transversion leading to a Cys2008Ser substitution was found in both patients from family 2. In a patient from a third family, an 8-base deletion from nucleotide 8437 to 8444 was identified in exon 51. The 2 mutations in exon 52 were reproduced by in vitro site-directed mutagenesis of full-length von Willebrand factor (vWF) cDNA and transiently expressed in COS-7 cells. The corresponding recombinant VWFs for these 2 mutations exhibited the typical aberrant vWF:Ag multimer pattern seen in the plasma of the patients. These 3 mutations demonstrate the importance of other carboxy-terminal cysteines in addition to the reported Cys2010 residue, in the normal dimerization of vWF, and their essential role in the assembly of normal multimeric vWF. (Blood. 2001;98:674-680)
Similar articles
-
Expression and characterization of von Willebrand factor dimerization defects in different types of von Willebrand disease.Blood. 2001 Apr 1;97(7):2059-66. doi: 10.1182/blood.v97.7.2059. Blood. 2001. PMID: 11264172
-
Impaired dimerization of von Willebrand factor subunit due to mutation A2801D in the CK domain results in a recessive type 2A subtype IID von Willebrand disease.Thromb Haemost. 2006 May;95(5):776-81. Thromb Haemost. 2006. PMID: 16676067
-
A new candidate missense mutation (Leu 1657 IIe) in an apparently asymptomatic type 2A (phenotype IIA) von Willebrand disease family.Thromb Haemost. 2000 Sep;84(3):369-73. Thromb Haemost. 2000. PMID: 11019957
-
Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.Acta Haematol. 2009;121(2-3):128-38. doi: 10.1159/000214853. Epub 2009 Jun 8. Acta Haematol. 2009. PMID: 19506359 Review.
-
Molecular genetics of type 2 von Willebrand disease.Int J Hematol. 2002 Jan;75(1):9-18. doi: 10.1007/BF02981973. Int J Hematol. 2002. PMID: 11843298 Review.
Cited by
-
Pseudo (platelet-type) von Willebrand disease in pregnancy: a case report.BMC Pregnancy Childbirth. 2013 Jan 17;13:16. doi: 10.1186/1471-2393-13-16. BMC Pregnancy Childbirth. 2013. PMID: 23327637 Free PMC article.
-
Biogenesis of Weibel-Palade bodies in von Willebrand's disease variants with impaired von Willebrand factor intrachain or interchain disulfide bond formation.Haematologica. 2012 Jun;97(6):859-66. doi: 10.3324/haematol.2011.057216. Epub 2011 Dec 29. Haematologica. 2012. PMID: 22207689 Free PMC article.
-
The disulfide bond Cys2724-Cys2774 in the C-terminal cystine knot domain of von Willebrand factor is critical for its dimerization and secretion.Thromb J. 2021 Nov 27;19(1):94. doi: 10.1186/s12959-021-00348-w. Thromb J. 2021. PMID: 34838051 Free PMC article.
-
Gene-centric approach identifies new and known loci for FVIII activity and VWF antigen levels in European Americans and African Americans.Am J Hematol. 2015 Jun;90(6):534-40. doi: 10.1002/ajh.24005. Epub 2015 Apr 1. Am J Hematol. 2015. PMID: 25779970 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous